Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

Cardiologists have warned for years that healthy adults with no family history of CVD should not be taking low-dose aspirin every day—but as the saying goes, old habits die hard. 

Medical students are broadly familiar with digital health technologies. Relatedly, they believe AI will play a crucial role in the future of healthcare. These are good signs for the advancement of evidence-based medicine. 

The so-called "weekend effect" seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well. 

Last week’s blastoff of the Chinese AI company DeepSeek struck many like a cold bucket of water in the face.

Wasn’t radiology the fastest medical specialty to embrace and adopt AI? And yet burnout continues to afflict many if not most radiologists. 

The physician shortage that U.S. hospitals and health systems have been dreading is here—and its impact on cardiology could be quite significant.

The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death.